olsalazine has been researched along with aminosalicylic acid in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Allgayer, H; Böhne, P; Gugler, R; Höfer, P; Kruis, W; Schmidt, M | 1 |
Aronson, JK; Crotty, B; Jewell, DP; Rosenberg, WM | 1 |
Crotty, B; Dalton, HR; Hoang, P; Jewell, DP | 1 |
Friedman, G | 1 |
Allgayer, H; Böhne, P; Gugler, R; Klotz, U; Kruis, W; Rang, S; Retey, J | 1 |
Dhaneshwar, SS | 1 |
Hou, T; Li, Y; Liang, X; Lin, H; Liu, F; Otkur, W; Pei, S; Piao, HL; Qi, H; Wang, J; Xiang, K; Yang, R; Zhang, X; Zhou, H | 1 |
3 review(s) available for olsalazine and aminosalicylic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Clinical Trials as Topic; Colon; Fatty Acids, Omega-3; Heparin, Low-Molecular-Weight; Humans; Inflammatory Bowel Diseases; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine | 2014 |
1 trial(s) available for olsalazine and aminosalicylic acid
Article | Year |
---|---|
Sulfasalazine and new analogues.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Enema; Humans; Mesalamine; Sulfasalazine | 1986 |
5 other study(ies) available for olsalazine and aminosalicylic acid
Article | Year |
---|---|
Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Direct evaluation with electron spin resonance spectroscopy.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Chromatography, High Pressure Liquid; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Humans; Hydroxides; Hydroxyl Radical; Inflammatory Bowel Diseases; Linoleic Acid; Linoleic Acids; Mesalamine; Spectrophotometry, Ultraviolet; Superoxides | 1992 |
Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Northern; Cell Line; Depression, Chemical; Dose-Response Relationship, Drug; HLA-DR Antigens; Humans; Inflammatory Bowel Diseases; Interferon-gamma; Mesalamine; Protein Binding; Receptors, Interferon; Tumor Cells, Cultured | 1992 |
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cell Line; Colchicine; Colon; Epithelium; Flow Cytometry; HLA-DR Antigens; Humans; Inflammatory Bowel Diseases; Interferon-gamma; Male; Mesalamine; Middle Aged; Salicylates | 1992 |
Superoxide inhibition following different stimuli of respiratory burst and metabolism of aminosalicylates in neutrophils.
Topics: Acetylation; Aminosalicylic Acid; Aminosalicylic Acids; Benzaldehydes; Free Radical Scavengers; Humans; Hydrazones; Mesalamine; Neutrophils; Respiratory Burst; Superoxides | 1994 |
Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; NF-kappa B; Prodrugs; Receptors, G-Protein-Coupled | 2023 |